Middle East Respiratory Syndrome Coronavirus Spike Protein Delivered by Modified Vaccinia Virus Ankara Efficiently Induces Virus-Neutralizing Antibodies

Middle East respiratory syndrome coronavirus (MERS-CoV) has recently emerged as a causative agent of severe respiratory disease in humans. Here, we constructed recombinant modified vaccinia virus Ankara (MVA) expressing full-length MERS-CoV spike (S) protein (MVA-MERS-S). The genetic stability and g...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Song, Fei, Fux, Robert, Provacia, Lisette B., Volz, Asisa, Eickmann, Markus, Becker, Stephan, Osterhaus, Albert D. M. E., Haagmans, Bart L., Sutter, Gerd
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2013
Soggetti:
Vaccines and Antiviral Agents
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3807317/
https://ncbi.nlm.nih.gov/pubmed/23986586
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.01672-13
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi